Sage Therapeutics is a biopharmaceutical company headquartered in Cambridge, Massachusetts and founded in 2010 by Douglas Covey and Steven Paul. The company develops medicines and therapies to treat disorders of the central nervous system.
On October 18, 2011 Sage Therapeutics closed their series A funding round with $35 million in funding from Third Rock Ventures.
On October 16, 2013 Sage Therapeutics closed their series B funding round with $20 million in funding from Third Rock Ventures and ARCH Venture Partners.
Chief Scientific Officer
Senior Vice President, Regulatory Affairs and Quality Assurance
Senior Vice President, people and Organizational Strategy
Senior Vice President, Technical Operations
CEO & Member of Board of Directors
Chief Research Officer
Chief Financial Officer
Chief Business Officer
Chief Medical Officer
Co-Founder & Board Member
Five things you don’t know about Jeff Jonas, CEO of Sage Therapeutics
Sage Therapeutics CEO: Have to weigh investor returns but will price postpartum drug 'fairly'
Documentaries, videos and podcasts